X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (89) 89
life sciences & biomedicine (86) 86
humans (67) 67
human necessities (54) 54
hygiene (54) 54
medical or veterinary science (54) 54
female (51) 51
male (49) 49
preparations for medical, dental, or toilet purposes (44) 44
specific therapeutic activity of chemical compounds ormedicinal preparations (41) 41
middle aged (34) 34
adult (32) 32
aged (29) 29
rivaroxaban (26) 26
gastroenterology & hepatology (23) 23
cardiovascular system & cardiology (22) 22
risk factors (20) 20
animals (19) 19
inflammatory bowel disease (19) 19
610 medicine & health (16) 16
anticoagulants (15) 15
peripheral vascular disease (15) 15
treatment outcome (15) 15
abridged index medicus (14) 14
aged, 80 and over (14) 14
anticoagulants - therapeutic use (14) 14
clinic for gastroenterology and hepatology (14) 14
administration, oral (13) 13
adolescent (13) 13
double-blind method (13) 13
factor xa inhibitors (13) 13
hematology (13) 13
anticoagulants - administration & dosage (12) 12
drug therapy (12) 12
prospective studies (12) 12
chemistry (11) 11
morpholines - administration & dosage (11) 11
morpholines - therapeutic use (11) 11
surgery (11) 11
thiophenes - administration & dosage (11) 11
thiophenes - therapeutic use (11) 11
atrial fibrillation (10) 10
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (10) 10
disinfection, sterilisation, or deodorisation of air (10) 10
internal medicine (10) 10
materials for bandages, dressings, absorbent pads, or surgicalarticles (10) 10
methods or apparatus for sterilising materials or objects ingeneral (10) 10
patients (10) 10
ulcerative colitis (10) 10
young adult (10) 10
anticoagulants - adverse effects (9) 9
cardiac & cardiovascular systems (9) 9
general & internal medicine (9) 9
medicine, general & internal (9) 9
morpholines - adverse effects (9) 9
thiophenes - adverse effects (9) 9
cardiovascular (8) 8
child (8) 8
cohort studies (8) 8
follow-up studies (8) 8
intestine (8) 8
medical clinic (8) 8
metallurgy (8) 8
radiology, nuclear medicine & medical imaging (8) 8
thrombosis (8) 8
biochemistry & molecular biology (7) 7
care and treatment (7) 7
crohn's disease (7) 7
dose-response relationship, drug (7) 7
enoxaparin - adverse effects (7) 7
enoxaparin - therapeutic use (7) 7
epidemiology (7) 7
factor xa (7) 7
heart failure (7) 7
hemorrhage - chemically induced (7) 7
heterocyclic compounds (7) 7
hospitals (7) 7
inflammatory bowel diseases (7) 7
organic chemistry (7) 7
switzerland - epidemiology (7) 7
time factors (7) 7
total hip replacement (7) 7
venous thromboembolism - prevention & control (7) 7
cardiology (6) 6
clinical trials (6) 6
colon (6) 6
fibrinolytic agents - therapeutic use (6) 6
health aspects (6) 6
heparin - therapeutic use (6) 6
kirurgi (6) 6
medicine & public health (6) 6
morpholines - pharmacokinetics (6) 6
patient outcomes (6) 6
rats (6) 6
sex factors (6) 6
stroke (6) 6
thiophenes - pharmacokinetics (6) 6
thromboembolism (6) 6
veins & arteries (6) 6
venous thromboembolism (6) 6
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (206) 206
French (14) 14
German (14) 14
Spanish (6) 6
Chinese (5) 5
Norwegian (4) 4
Portuguese (4) 4
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9676, pp. 1673 - 1680
Summary Background Prophylaxis for venous thromboembolism is recommended for at least 10 days after total knee arthroplasty; oral regimens could enable shorter... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Arthroplasty, Replacement, Knee - adverse effects | Follow-Up Studies | Thiophenes - adverse effects | Humans | Middle Aged | Venous Thrombosis - diagnostic imaging | Male | Enoxaparin - therapeutic use | Incidence | Rivaroxaban | Sensitivity and Specificity | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Risk Reduction Behavior | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Venous Thrombosis - etiology | Phlebography | Analysis of Variance | Venous Thrombosis - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Enoxaparin | Anticoagulants (Medicine) | Dosage and administration | Thrombophlebitis | Comparative analysis | Risk factors | Studies | Blood transfusions | Sensitivity analysis | Medical imaging | Hospitals | Protease inhibitors | Surgery | Joint surgery | Drug therapy | Thrombosis | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Knee | Venous Thrombosis | Oral | Hemorrhage | epidemiology | Thiophenes | Administration | Anticoagulants | chemically induced | Arthroplasty | Replacement | prevention & control | radiography | Morpholines | Kirurgi | etiology | adverse effects | therapeutic use
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2008, Volume 358, Issue 26, pp. 2776 - 2786
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2008, Volume 358, Issue 26, pp. 2765 - 2775
.... Huisman, M.D., Ph.D., Ajay K. Kakkar, M.D., Ph.D., Tiemo J. Bandel, M.D., Horst Beckmann, Ph.D., Eva Muehlhofer, M.D., Frank Misselwitz, M.D., Ph.D., and William... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article